Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cryo Cell International (CCEL) Debt to Equity: 2010-2025

Historic Debt to Equity for Cryo Cell International (CCEL) over the last 16 years, with Q3 2025 value amounting to -$0.77.

  • Cryo Cell International's Debt to Equity rose 3033.73% to -$0.77 in Q3 2025 from the same period last year, while for Aug 2025 it was -$0.77, marking a year-over-year increase of 3033.73%. This contributed to the annual value of -$0.9 for FY2024, which is 229.59% down from last year.
  • Latest data reveals that Cryo Cell International reported Debt to Equity of -$0.77 as of Q3 2025, which was up 3033.73% from -$0.95 recorded in Q2 2025.
  • Over the past 5 years, Cryo Cell International's Debt to Equity peaked at $0.22 during Q2 2021, and registered a low of -$692.39 during Q3 2023.
  • Moreover, its 5-year median value for Debt to Equity was -$0.9 (2024), whereas its average is -$38.81.
  • Its Debt to Equity has fluctuated over the past 5 years, first soared by 13212.9% in 2022, then crashed by 1908541.08% in 2023.
  • Cryo Cell International's Debt to Equity (Quarter) stood at $0.21 in 2021, then crashed by 3504.7% to -$7.12 in 2022, then soared by 87.71% to -$0.88 in 2023, then dropped by 2.3% to -$0.9 in 2024, then grew by 14.08% to -$0.77 in 2025.
  • Its last three reported values are -$0.77 in Q3 2025, -$0.95 for Q2 2025, and -$0.88 during Q1 2025.